Lv12
80 积分 2025-09-08 加入
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
3小时前
待确认
Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
7小时前
已完结
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
1天前
已完结
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer
3天前
已完结
Diagnostic performance of Xpert MTB/RIF Ultra assay with pulmonary and extrapulmonary specimens: a retrospective evaluation in a low incidence setting in Finland
23天前
已完结
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
1个月前
已完结
Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification
1个月前
已完结
ENDOESTRO score: where is the dark side? Evaluation of estrogen receptor expression cutoff in endometrial cancer molecular classification, an ambispective study
1个月前
已完结
皖公网安备34019202002308
